Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Stock-Based Compensation - Options Activity (Details)

v3.23.3
Stockholders' Equity and Stock-Based Compensation - Options Activity (Details) - 2022 Omnibus Plan - Stock options
 9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Number of Options    
Balances at the beginning | shares 254,000  
Granted | shares 135,015  
Exercised | shares (133)  
Forfeited | shares (26,215)  
Balances at the ending | shares 362,667 254,000
Vested and exercisable at September 30, 2023 | shares 77,130  
Weighted-Average Exercise Price    
Balances at the beginning (in dollars per share) | $ / shares $ 1.69  
Granted (in dollars per share) | $ / shares 3.96  
Exercised (in dollars per share) | $ / shares 1.62  
Forfeited (in dollars per share) | $ / shares 2.22  
Balances at the ending (in dollars per share) | $ / shares 2.49 $ 1.69
Vested and exercisable at September 30, 2023 (in dollars per share) | $ / shares $ 1.62  
Weighted Average Contractual Life (in years)    
Granted (in years) 9 years 5 months 19 days  
Balances at the ending (in years) 8 years 11 months 23 days 8 years 9 months 3 days
Vested and exercisable at September 30, 2023 (in years) 8 years 8 months 15 days  
Aggregate Intrinsic Value    
Granted (intrinsic value) | $ $ 24,303  
Exercised | $ 93  
Forfeited | $ 33,550  
Outstanding | $ 207,788 $ 193,486
Vested and exercisable at September 30, 2023 (intrinsic value) | $ $ 68,837